Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.
about
The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimagingThe effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm mazeStriatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.Targeting the dopamine D3 receptor: an overview of drug design strategies.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.The Role of the Serotonergic System in REM Sleep Behavior Disorder.Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptorsRegulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease.Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.Individualizing clozapine and risperidone treatment for schizophrenia patients.Levodopa effects on [ (11)C]raclopride binding in the resting human brainPositron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats.Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls.Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease.Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic CSelectivity of probes for PET imaging of dopamine D3 receptors.Distinct Roles of Dopamine Receptors in the Lateral Thalamus in a Rat Model of Decisional Impulsivity.Is There Evidence for a Rostral-Caudal Gradient in Fronto-Striatal Loops and What Role Does Dopamine Play?
P2860
Q26865047-A711F784-DB0D-4C81-AEF7-159E5496AEE4Q30661702-D8AB0057-D0F3-465D-923B-2D2535AA2D0BQ33863502-9A79D127-A4CE-4D59-ADD8-88C2863DF255Q33944031-933D7961-F118-4E0D-833F-52FA9393E171Q34375709-063B9DA0-9849-4117-947A-40371172B29EQ34524556-44334E64-AFBD-481D-8CF6-C2E436EF78CCQ35892818-DC9729A0-553B-49A5-AA11-74FB13C7D0D1Q35936402-2A9850DD-8D5E-42B3-A711-3467CC52E671Q35965848-D5C03A53-3771-4402-8021-A137C6E84FF0Q36727004-F8C7124E-2DAC-49B2-9EBB-D6D9178EAB32Q37140503-66071862-95CF-4874-B284-E620954AB9DDQ37228453-2965B43D-6DBE-43E1-A6BC-302B32317D9DQ37568555-19C9903D-BA12-4EF4-BC5F-EEB0F370DD08Q38170458-A40CD3C1-353D-4F41-BD8F-F4218E48C4C1Q40730465-6E6845C4-499D-4731-8750-BECD2F30C877Q41998180-A9E302F3-1018-4260-BAF1-FCBD06F85F43Q42700995-7AD3FD83-60F8-42D2-A617-6FCEA34731A2Q42840319-15E8F2B5-4448-4003-A66B-B5E947B44A16Q45289206-E760F519-0320-437A-BC68-213146BCF508Q45729007-49D4DF65-0D21-49CA-8F9B-EE1C0BEDAA02Q47178205-4433572A-E1D2-4032-868C-4EA53A3BB30FQ47380939-7F2782C4-DED8-4BCC-8338-CDCA158A1B0BQ47759449-71113C9C-42C6-4391-A5BF-83F0C26CFBEFQ48149406-1DFB2B79-AEA3-4D1D-A4AC-AB06AA606639Q48451343-285AE9A1-FF19-4B92-A37E-4726AEBDA368Q52316241-A3D548E3-4C06-438B-B01A-50B8A45E69F6Q53596033-A0185688-2613-40CA-BD8E-C40A7D821AE5Q55182404-F087D33C-64AD-4C9A-9A95-814EAA8A3F3C
P2860
Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@ast
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@en
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@nl
type
label
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@ast
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@en
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@nl
prefLabel
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@ast
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@en
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@nl
P2093
P2860
P1433
P1476
Dopamine D1, D2, D3 receptors, ...... densities in aged human brain.
@en
P2093
Jianjun Sun
Nigel J Cairns
Robert H Mach
P2860
P304
P356
10.1371/JOURNAL.PONE.0049483
P407
P577
2012-11-21T00:00:00Z